Fan, Y.-C.; Peng, S.-Y.; Chang, C.-K.; Lee, C.-Y.; Huang, J.-Y.; Hsieh, M.-J.; Yang, S.-F.
The Utilization of Glucagon-like Peptide 1 Agonists and Risk of Following External Eye Diseases in Type 2 Diabetes Mellitus Individuals: A Population-Based Study. Healthcare 2023, 11, 2749.
https://doi.org/10.3390/healthcare11202749
AMA Style
Fan Y-C, Peng S-Y, Chang C-K, Lee C-Y, Huang J-Y, Hsieh M-J, Yang S-F.
The Utilization of Glucagon-like Peptide 1 Agonists and Risk of Following External Eye Diseases in Type 2 Diabetes Mellitus Individuals: A Population-Based Study. Healthcare. 2023; 11(20):2749.
https://doi.org/10.3390/healthcare11202749
Chicago/Turabian Style
Fan, Ying-Chi, Shu-Yen Peng, Chao-Kai Chang, Chia-Yi Lee, Jing-Yang Huang, Ming-Ju Hsieh, and Shun-Fa Yang.
2023. "The Utilization of Glucagon-like Peptide 1 Agonists and Risk of Following External Eye Diseases in Type 2 Diabetes Mellitus Individuals: A Population-Based Study" Healthcare 11, no. 20: 2749.
https://doi.org/10.3390/healthcare11202749
APA Style
Fan, Y. -C., Peng, S. -Y., Chang, C. -K., Lee, C. -Y., Huang, J. -Y., Hsieh, M. -J., & Yang, S. -F.
(2023). The Utilization of Glucagon-like Peptide 1 Agonists and Risk of Following External Eye Diseases in Type 2 Diabetes Mellitus Individuals: A Population-Based Study. Healthcare, 11(20), 2749.
https://doi.org/10.3390/healthcare11202749